Pfizer stock fell on pessimistic guidance as the company prepares to drop a Covid vaccine
font size Pfizer said it expects Covid-19 vaccine sales to fall to $13.5 billion in 2023. Mario Tama/Getty Images Pfizer Tuesday set guidance for fiscal year 2023 well below Wall Street consensus numbers, dampening investor expectations ahead of what is expected to be a sharp drop in sales of Covid-19 products. Shares fell 3% in …
